Your browser doesn't support javascript.
loading
Application of PET/MRI in Gynecologic Malignancies.
Ebrahimi, Sheida; Lundström, Elin; Batasin, Summer J; Hedlund, Elisabeth; Stålberg, Karin; Ehman, Eric C; Sheth, Vipul R; Iranpour, Negaur; Loubrie, Stephane; Schlein, Alexandra; Rakow-Penner, Rebecca.
Affiliation
  • Ebrahimi S; Department of Radiology, University of California San Diego, La Jolla, CA 92093, USA.
  • Lundström E; Department of Radiology, University of California San Diego, La Jolla, CA 92093, USA.
  • Batasin SJ; Department of Surgical Sciences, Radiology, Uppsala University, 751 85 Uppsala, Sweden.
  • Hedlund E; Center for Medical Imaging, Uppsala University Hospital, 751 85 Uppsala, Sweden.
  • Stålberg K; Department of Radiology, University of California San Diego, La Jolla, CA 92093, USA.
  • Ehman EC; Department of Surgical Sciences, Radiology, Uppsala University, 751 85 Uppsala, Sweden.
  • Sheth VR; Department of Women's and Children's Health, Uppsala University, 751 85 Uppsala, Sweden.
  • Iranpour N; Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
  • Loubrie S; Department of Radiology, Stanford University, Palo Alto, CA 94305, USA.
  • Schlein A; Department of Radiology, Stanford University, Palo Alto, CA 94305, USA.
  • Rakow-Penner R; Department of Radiology, University of California San Diego, La Jolla, CA 92093, USA.
Cancers (Basel) ; 16(8)2024 Apr 12.
Article in En | MEDLINE | ID: mdl-38672560
ABSTRACT
The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2024 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2024 Type: Article Affiliation country: United States